The Supreme Court recently noted that "employers are generally required to provide coverage for 20 contraceptive methods approved by the Food and Drug Administration, including 4 that may have the effect of preventing an already fertilized egg from developing any further by inhibiting its attachment to the uterus."
This is not true. But the FDA still tells consumers that contraceptives "may inhibit implantation" of a fertilized egg - even in the face of evidence that shows they do not. Its European counterpart, the EMA, has already removed these false labels for emergency contraceptives, but the FDA has made no move to do so.
Updating the labeling for levonorgestrel products like Plan B will help to move the conversation on this issue beyond myths about abortifacient contraceptives.



